Clinical Trial Update: Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of enasidenib with cobimetinib for relapsed or refractory acute myeloid leukemia; the study is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cotellic (cobimetinib)
• IDHIFA (enasidenib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING